Leading in Medical Technology

Economy is Driving Many Osteoporotic Women to Retire Later - But Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease

... can form as a result of lower levels of estrogen, leading to osteoporosis.(17) In fact, women can lose up ... women to more actively manage their disease, six leading women's advocacy groups have joined forces to ... Osteoporosis Foundation (NOF) is the nation's leading voluntary health organization solely dedicated to ...

FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent

... factor for cardiovascular disease, the number one leading cause of death in the US. If left untreated, ... researches, develops, manufactures and markets leading innovative prescription drugs used to treat a ... products. Novartis is the only company with leading positions in these areas. In 2008, the Group's ...

Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease

... not-for-profit group practice in the world. As a leading academic medical center in the Southwest, Mayo ... for new treatments. Banner Health is Arizona's leading health care provider and second largest private ... The University of Arizona is one of the nation's leading public universities, with a long history of ...

First Patient of NOTES Investigational Device Exemption (IDE) Study Successfully Treated With Ethicon Endo-Surgery Devices

... external incisions are eliminated, potentially leading to reduced pain, a quicker recovery and a faster ... Ethicon Endo-Surgery is committed to working with leading medical intuitions and societies, which we ... external incisions are eliminated, potentially leading to reduced pain, a quicker recovery and a faster ...

Alcon Commences Phase 2 Clinical Trial of NovaBay's NVC-422 for Viral Conjunctivitis

... condition that affects both adults and children, leading to more than four million doctor and emergency ... collaboration agreement with Alcon, the world's leading eye care company, for use of its Aganocide(R) ... About Alcon Alcon, Inc. is the world's leading eye care company, with sales of approximately ...

Brain Fitness Makes Boomers Age Younger

... Jeff Zimman, Chairman of Posit Science, the leading provider of brain fitness software , addressed ... Posit Science Posit Science is the leading provider of scientifically proven brain fitness ... test its computer-based programs. More than 30 leading science and medical journals show that in ...

VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers

... June 8 /PRNewswire/ -- VivoMetrics, Inc., a leading innovator in remote patient monitoring (RPM), ... in 1999 and based in Ventura, Calif., is a leading innovator in next generation remote patient ... and clinical trials using LifeShirt at nearly 300 leading research and academic institutions across a wide ...

Perceptive Informatics Enhances Investigator Application of New RECIST Version in Imaging-Based Oncology Trials

... -- Perceptive Informatics, the industry's leading eClinical solutions provider and a subsidiary of ... 1.1 toolset Perceptive Informatics maintains a leading position with respect to incorporation of the ... a subsidiary of PAREXEL, is the industry's leading eClinical solutions provider. Perceptive ...

Carbapenems and Other Agents that Provide Broad-Spectrum Activity are Preferred by Surveyed Physicians for the Treatment of Intra-Abdominal Infections

... A Drug's Activity Against Anaerobes is the leading Attribute in Antibiotic Selection, According to a ... with an intra-abdominal infection. In fact, the leading attribute that physicians surveyed look for in a ... cite a drug's activity against anaerobes as the leading attribute in antibiotic selection. ...

PAREXEL Reaches Milestone in Management of Oncology Trials Over Last Five Years Involving 175,000 Patients Worldwide

... International Corporation (Nasdaq: PRXL ), a leading global biopharmaceutical services provider, today ... and relationships its experts have with leading cancer centers and key opinion leaders in its ... PAREXEL International Corporation is a leading global biopharmaceutical services organization, ...

Stand Up To Cancer Awards $73.6 Million for Novel, Groundbreaking Cancer Research

... Selected With More Than 200 Researchers from 20 leading Institutions Initiative's Pioneering ... quick pace. The Dream Teams bring together leading laboratory scientists and physicians, ... and 27 principal researchers from over 20 leading institutions, with more than 300 individuals ...

Lions Eye Institute for Transplant & Research, Inc. Launches Multi-Million Dollar, State-of-the-Art Research Institute that Will Advance the Study of Blinding Eye Diseases

... of Americans. Macular degeneration is the leading cause of visual loss in the elderly and the ... new cases of blindness each year and is the leading cause of blindness among African Americans. LEITR's initial research platforms will explore the leading causes of these two blinding diseases, providing ...

Potentia Pharmaceuticals' POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II

... Degeneration) clinical trial for the company's leading drug candidate, POT-4. The ASaP trial was an ... dry and wet AMD. About AMD AMD is the leading cause of blindness in the elderly of the western ... involving dozens of plasma proteins, ultimately leading to cell membrane disruption through the membrane ...

Perceptive Informatics Survey Results Reveal Top Barriers to Implementing Adaptive Trial Designs

... -- Perceptive Informatics, the industry's leading eClinical solutions provider and a subsidiary of ... a subsidiary of PAREXEL, is the industry's leading eClinical solutions provider. Perceptive ... PAREXEL International Corporation is a leading global biopharmaceutical services organization, ...

Perceptive Informatics Introduces Medical Imaging Methodology to Accelerate Development Decisions About Alzheimer's Treatments

... -- Perceptive Informatics, the industry's leading eClinical solutions provider and a subsidiary of ... to effective treatments for Alzheimer's disease, leading to effective prevention. More information about ... a subsidiary of PAREXEL, is the industry's leading eClinical solutions provider. Perceptive ...

ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients

... believe the data continue to position ANA598 as a leading non-nucleoside polymerase inhibitor in ... was completed in the first quarter of 2008, leading to submission of an Investigational New Drug ... liver resulting from chronic HCV infection is the leading indication for liver transplantation in the U.S. ...

SAFC Biosciences(R) and Vivalis Collaborate to Optimize Cell Culture Media for Vaccines Production

... About SAFC Biosciences: SAFC Biosciences is a leading provider of cell culture materials and ... history as a manufacturing partner providing leading biopharmaceutical companies with the broadest ... About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Its ...

New Report Shows Record Number of Medicines in Development to Treat Leading Causes of Cancer

... Nationwide, cancer is the second leading cause of death, affecting more than 10 million ... being developed include 122 for lung cancer, the leading cause of cancer death in the United States; 107 ... of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology ...

DaVita Abstracts Accepted Into National Kidney Foundation's 2009 Spring Symposium

... Calif., March 25 /PRNewswire/ -- DaVita Inc., a leading provider of kidney care services for those ... TN. The meeting is a platform for the nation's leading renal health care providers to learn about new ... DaVita Inc., a FORTUNE 500(R) company, is a leading provider of kidney care in the United States, ...

Leader in Prostate Health Urges Prostate Cancer Screening in Face of Contradicting Data

... than skin cancers, in American men and the second leading cause of cancer death in American men, behind ... Cancer Education Council - is the nation's leading resource for information on prostate health. The ... The Council - comprised of a consortium of leading physicians, health educators, scientists and ...

The Lancet Publishes Two-Year Results of Abbott's Fully Bioabsorbable Drug Eluting Stent

... today in The Lancet , one of the world's leading medical journals, from the ABSORB clinical trial ... is another example of scientific innovation leading to an interventional breakthrough," said John M. ... a division of Abbott, is one of the world's leading vascular care businesses. Abbott Vascular is ...

R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges

... economy." Record investment in R&D is leading America's biopharmaceutical companies toward ... of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology ... and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA ...

CyberKnife Radiosurgery for Lung Cancer Sees Increased Interest and Continued Rapid Growth

... of CyberKnife radiosurgery, with lung being the leading extracranial indication by utilization in ... this group of physicians. Discussions by leading thoracic surgeons, such as James Luketich, M.D., ... more than 155 systems have been installed in leading hospitals in the Americas, Europe and Asia. For ...

Report on 300 New Medicines in Development for Heart Disease and Stroke Released in Indianapolis

... because cardiovascular disease and stroke are the leading causes of death in the state. Indiana also ranks ... of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology ... and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA ...

IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile

... Medical today announced that one of the leading surgeons in Chile, Dr. Sebastian von Unger, has ... strength with a minimal scar. He was working and leading a normal life." Said Bob Rabiner, Founder ... Hospital del Trabajadar is one of the leading hospitals in Chile. Its orthopedic department is ...

The Quigley Corporation Licenses Naturally Derived Compound For Scar Improvement; License Requires Payments Totaling $1.1 Million To The Quigley Corporation Over A Five Year Period For Exclusive Ownership

... of scars in a comparative study versus a category leading OTC national brand name scar cream. Dr ... science company. Its Cold Remedy segment is a leading marketer and manufacturer of the COLD-EEZE(R) ... cold nearly in half. COLD-EEZE customers include leading national wholesalers and distributors, as well as ...

New Proton Therapy Equipment Enables More Tumors to be Treated

... step in improving delivery of protons, eventually leading to more intense and fewer doses and the potential ... and the UF Proton Therapy Institute. IBA is the leading manufacturer of particle therapy equipment, with ... ABOUT IBA: IBA develops and markets leading edge technologies, pharmaceuticals and ...

Parkinson's Disease Foundation Awards $300,000 in Bridge Funding for Innovative Research Projects

... $300,000 in emergency bridge funding to four leading Parkinson's disease scientists. The grants will ... Grants Program, which funds research at three leading universities; the International Research Grants ... Parkinson's Disease Foundation(R) (PDF(R)) is a leading national presence in Parkinson's disease ...

New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation

... conditions. Atrial fibrillation is the leading cause of hospitalization for arrhythmia in the ... events, serious adverse events and adverse events leading to study drug discontinuation. About ... About sanofi-aventis Sanofi-aventis, a leading global pharmaceutical company, discovers, ...

ESBATech's Antibody Fragment Enters Phase Ib/IIa in Ophthalmology

... Feb. 3 /PRNewswire/ -- ESBATech AG, a leading developer of antibody fragment therapeutics, ... changes in the lens structure. Cataracts are the leading cause of vision loss in adults that are 55 and older and are the leading cause of blindness worldwide. By age 65, about ...

British Midlands University Announces Use of Gene Technology to Fight Lethal Hospital Acquired Infection

... University of Nottingham Scientists leading Major Study into Lethal 'Super' Strains of ... scientists at The University of Nottingham are leading a major European study to unravel the genetic ... lining and releasing two toxins that damage cells leading to the tell-tale symptom of severe diarrhea. ...

American Dairy Provides Business Update

... American Dairy, Inc. (NYSE Arca: ADY), one of the leading producers and distributors of premium infant ... participated in the sales training conducted by leading industry experts. American Dairy's Feihe ... In July 2007, Feihe Dairy was named "National leading Enterprise of Agricultural Industrialization" by ...

Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding

... for Heart Failure Cardio3 BioSciences, a leading Belgian biotechnology company specialising in ... development is being guided by some of the leading clinicians in the field in Europe and the ... The active participation of a number of world leading cardiologists in the clinical development of ...

RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments

... patients - Gastric cancer is the second leading cause of cancer death worldwide with the majority ... researches, develops, manufactures and markets leading innovative prescription drugs used to treat a ... products. Novartis is the only company with leading positions in these areas. In 2007, the Group's ...

Pfizer Contributes Critical Data to URMC Drug Safety Initiative

... attacks. Sudden cardiac arrest is the leading cause of death in the United States, resulting in ... episodes of fatal ventricular arrhythmias is a leading cause of removal of drugs from the market and was a leading impetus toward international collaboration to ...

WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System

... Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art gene expression, ... Based on collaborations established with leading research institutions, WaferGen believes that the ... markets. Based on collaborations established with leading research institutions, WaferGen believes that the ...

ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients

... this early data continues to position ANA598 as a leading non-nucleoside polymerase inhibitor in ... was completed in the first quarter of 2008, leading to submission of an Investigational New Drug ... liver resulting from chronic HCV infection is the leading indication for liver transplantation in the U.S. ...

RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial

... cancer among women in the US and the second leading cause of cancer-related death in women. Breast ... researches, develops, manufactures and markets leading innovative prescription drugs used to treat a ... products. Novartis is the only company with leading positions in these areas. In 2007, the Group's ...

Two New Studies in the New England Journal of Medicine Show Malaria Vaccine Candidate Advancing in Africa

... (ASTMH) annual meeting. RTS,S/AS is the leading candidate in a global effort coordinated by ... Trial Partnership Committee, a collaboration of leading African research institutes, Northern academic ... itself in a short time period as a leading clinical trial site and has made a significant ...

S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis

... a potent and orally-active JAK2 inhibitor, in leading medical centers in Australia for patients with ... molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and ... In line with its vision to be a leading fully-integrated oncology-focused biotech company ...